Aurobindo Pharma’s arm gets EIR for Andhra Pradesh facility

18 Sep 2024 Evaluate

Aurobindo Pharma’s stepdown subsidiary -- Eugia Steriles has received Establishment Inspection Report (EIR) from the United States Food and Drug Administration (USFDA) for its new injectable facility situated at Parawada Mandal, Anakapalli District, Andhra Pradesh. The USFDA had conducted an inspection from March 28, 2024 to April 05, 2024 at this facility. The said inspection is closed.

Aurobindo Pharma is engaged in manufacturing pharmaceutical products. It offers active pharmaceutical ingredients, intermediates and generic formulations like astemizole, domeperidone and omeprazole; anti-infective, oral and sterile antibiotics, pain management and osteoporosis segments.


Aurobindo Pharma Share Price

1220.20 -27.70 (-2.22%)
21-Nov-2024 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1777.65
Dr. Reddys Lab 1194.55
Cipla 1465.65
Lupin 2043.30
Zydus Lifesciences 944.25
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.